產(chǎn)品名稱 | 乳腺癌相關(guān)蛋白2抗體 |
英文名稱 | Anti-BCAS2 |
規(guī)格 | 0.1ml/100μg 0.2ml/200μg |
濃度 | 1mg/1ml |
價格 | 來電可享受優(yōu)惠 |
英文名稱 Anti-BCAS2
中文名稱 乳腺癌相關(guān)蛋白2抗體
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse,Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 腫瘤 細胞生物 腫瘤細胞生物標志物 表觀遺傳學
蛋白分子量 predicted molecular weight: 26kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from humanBCAS2 (162-210aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1%BSA, 0.01M PBS, pH 7.4
產(chǎn)品應用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -39 °C for oneyear.
別 名 DNA amplified in mammary carcinoma 1 protein;Spliceosome associated protein SPF 27; bcas2; Breast carcinoma amplifiedsequence 2; Breast carcinoma-amplified sequence 2; DAM1; MGC7712; Pre mRNAsplicing factor SPF27; Pre-mRNA-splicing factor spf27; SPF27_HUMAN; Spliceosomeassociated protein amplified in breast cancer; Spliceosome-associated proteinSPF 27.
